Drug Repurposing for Duchenne Muscular Dystrophy: The Monoamine Oxidase B Inhibitor Safinamide Ameliorates the Pathological Phenotype in Mice and in Myogenic Cultures From DMD Patients

about

Drug Repurposing for Duchenne Muscular Dystrophy: The Monoamine Oxidase B Inhibitor Safinamide Ameliorates the Pathological Phenotype in Mice and in Myogenic Cultures From DMD Patients

Item

http://www.wikidata.org/entity/Q58781307

description

article

@en

im Januar 2018 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2018

@uk

name

Drug Repurposing for Duchenne ...... nic Cultures From DMD Patients

@en

Drug Repurposing for Duchenne ...... nic Cultures From DMD Patients

@nl

type

Item

label

Drug Repurposing for Duchenne ...... nic Cultures From DMD Patients

@en

Drug Repurposing for Duchenne ...... nic Cultures From DMD Patients

@nl

prefLabel

Drug Repurposing for Duchenne ...... nic Cultures From DMD Patients

@en

Drug Repurposing for Duchenne ...... nic Cultures From DMD Patients

@nl

P1476

Drug Repurposing for Duchenne ...... nic Cultures From DMD Patients

@en

P2093

Elisa Sorato

http://www.w3.org/2001/XMLSchema#string

Giada Forestan

http://www.w3.org/2001/XMLSchema#string

Leonardo Salviati

http://www.w3.org/2001/XMLSchema#string

Manuel Acosta

http://www.w3.org/2001/XMLSchema#string

Manuela Marabita

http://www.w3.org/2001/XMLSchema#string

Marcella Canton

http://www.w3.org/2001/XMLSchema#string

Vincent Mouly

http://www.w3.org/2001/XMLSchema#string

P2860

Cyclosporin A corrects mitochondrial dysfunction and muscle apoptosis in patients with collagen VI myopathies

Structure of human monoamine oxidase B, a drug target for the treatment of neurological disorders

Sterile inflammation: sensing and reacting to damage

Monoamine oxidase inhibition prevents mitochondrial dysfunction and apoptosis in myoblasts from patients with collagen VI myopathies.

Oxidative stress and the pathogenesis of muscular dystrophies.

Mitochondrial dysfunction reveals the role of mRNA poly(A) tail regulation in oculopharyngeal muscular dystrophy pathogenesis

Mitochondrial dysfunction in the pathogenesis of Ullrich congenital muscular dystrophy and prospective therapy with cyclosporins

Crystal structure of human monoamine oxidase B, a drug target enzyme monotopically inserted into the mitochondrial outer membrane.

The therapeutic potential of monoamine oxidase inhibitors.

Molecular mechanisms of muscular dystrophies: old and new players.

P304

1087

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FPHYS.2018.01087

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P50

L Nogara

Bert Blaauw

Libero Vitiello

P577

2018-08-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30154729

http://www.w3.org/2001/XMLSchema#string

P932

6102489

http://www.w3.org/2001/XMLSchema#string